FEDERATED HERMES, INC. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$27,964
-42.4%
1,140
-45.3%
0.00%
Q1 2023$48,541
+6.5%
2,086
+15.9%
0.00%
Q4 2022$45,558
-99.0%
1,800
-99.2%
0.00%
-100.0%
Q3 2022$4,587,000
+229250.0%
237,913
+321404.1%
0.01%
Q1 2022$2,000
-99.8%
74
-99.7%
0.00%
-100.0%
Q1 2020$893,00026,0580.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$40,100,00021.56%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$571,412,0002.71%
Nan Fung Group Holdings Ltd 210,563$5,416,0002.57%
Taikang Asset Management (Hong Kong) Co Ltd 533,332$13,717,0002.34%
Crawford Lake Capital Management, LLC 168,200$4,326,0001.80%
BOULDER HILL CAPITAL MANAGEMENT LP 126,900$3,264,0001.75%
Zebra Capital Management LLC 22,227$572,0001.31%
Alaska Permanent Fund Corp 2,300,000$59,156,0000.98%
CLARK ESTATES INC/NY 180,000$4,630,0000.73%
Temasek Holdings (Private) Ltd 5,602,553$144,097,6630.61%
View complete list of VIR BIOTECHNOLOGY INC shareholders